Latest Breaking News On - Adenosine deaminase acting - Page 2 : comparemela.com

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sarah kielyRobert stanislaroPeter kelleherExchange commissionCorporate developmentEuropean patent officeOpposition divisionChief corporate development officerAdenosine deaminase acting

ProQR Therapeutics N V : ProQR Announces Year End 2023 Operating and Financial Results

ProQR Therapeutics N V : ProQR Announces Year End 2023 Operating and Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSarah kielyPeter kelleherRobert stanislaroEli lillyStefan klotterInternational conference on base editingExchange commissionCompany lillyRett syndrome research trustRett syndrome researchJapanese patent officeCholestatic diseasesCardiovascular diseaseChief executive officerInternational conference

ProQR Announces Year End 2023 Operating and Financial Results

ProQR Announces Year End 2023 Operating and Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSarah kielyRobert stanislaroPeter kelleherEli lillyJapanese patent officeInternational conference on base editingRett syndrome research trustCompany lillyRett syndrome researchExchange commissionYear endCholestatic diseasesCardiovascular diseaseChief executive officerInternational conference

ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing

ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Peter kelleherRobert stanislaroSarah kielyJapanese patent officeExchange commissionCorporate developmentJapanese axiomerChief corporate development officerAdenosine deaminase acting

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

Platform demonstrates robust in vivo editing capabilities reporting up to 70% editing of ACTB in the liver of non-human primates (NHPs) and miceFunctional effect demonstrated in mice in vivo via modulation of ANGPLT3 protein properties leading to favorable increase in LPL enzymatic activity and meaningful impact of biomarkersAdditional data to be presented throughout 2024, including in vitro and in vivo data for pipeline programs AX-0810 for Cholestatic diseases targeting NTCP and AX-1412 for Ca

San diegoUnited statesSarah kielyPeter kelleherGerard platenburgEli lillyRobert stanislaroExchange commissionInternational conference on base editingInternational conferenceBase editingPrime editingRelated enzymesChief scientific officerEditing oligonucleotidesAdenosine deaminase acting